November 2024
1. PARAJULI S, Zona E, Breyer I, Tamburrini R, et al
   Risk Factors for Developing Advanced Chronic Kidney Disease in Pancreas Transplant Alone Recipients.
   Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005273.
   

   >> Share

   
   October 2024
2. SATAPATHY SK, Elwir S, Brandman D, Smith C, et al
   Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH Consortium.
   Transplantation. 2024 Oct 22. doi: 10.1097/TP.0000000000005236.
   

   >> Share

   
   September 2024
3. JORDAN SC
   Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts.
   Transplantation. 2024 Sep 16. doi: 10.1097/TP.0000000000005206.
   

   >> Share

   
   August 2024
4. SHOJI J, Goggins WC, Wellen JR, Cunningham PN, et al
   Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.
   Transplantation. 2024;108:1782-1792.
   

   >> Share

   
   July 2024
5. CROSS A, Issa F
   Unraveling Renal Transplant Rejection: How Can We Measure Intragraft Cell-Cell Interactions?
   Transplantation. 2024 Jul 24. doi: 10.1097/TP.0000000000005136.
   

   >> Share

   
   
6. MCCULLOUGH K
   Waitlist Time, Age, and Social Vulnerability: Impact on the Survival Benefit of Deceased Donor Kidney Transplantation Versus Long-term Dialysis Among Patients With End-stage Renal Disease.
   Transplantation. 2024 Jul 17. doi: 10.1097/TP.0000000000005149.
   

   >> Share

   
   
7. YANG J, Endo Y, Munir MM, Woldesenbet S, et al
   Waitlist Time, Age, and Social Vulnerability: Impact on the Survival Benefit of Deceased Donor Kidney Transplantation Versus Long-term Dialysis Among Patients With End-stage Renal Disease.
   Transplantation. 2024 Jul 12. doi: 10.1097/TP.0000000000005125.
   

   >> Share

   
   June 2024
8. BROOK MO, Hennessy C, Hester J, Hammad S, et al
   Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.
   Transplantation. 2024 Jun 7. doi: 10.1097/TP.0000000000005065.
   

   >> Share

   
   May 2024
9. SANDAL S, Ahn J, Chen Y, Thompson V, et al
   Differences in Racial and Ethnic Disparities Between First and Repeat Kidney Transplantation.
   Transplantation. 2024 May 21. doi: 10.1097/TP.0000000000005051.
   

   >> Share

   
   
10. QUINT EE, Pol RA, Segev DL, McAdams-DeMarco MA, et al
    Age Is Just a Number for Older Kidney Transplant Patients.
    Transplantation. 2024 May 21. doi: 10.1097/TP.0000000000005073.
    

    >> Share

    
    
11. 
    Clinical Research in Renal Transplantation: A Bibliometric Perspective on a Half-century of Innovation and Progress: Erratum.
    Transplantation. 2024;108:e80.
    

    >> Share

    
    August 2023
12. CHEN Y, Churilla B, Ahn JB, Quint EE, et al
    Age Disparities in Access to First and Repeat Kidney Transplantation.
    Transplantation. 2023 Aug 1. doi: 10.1097/TP.0000000000004747.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share